scholarly article | Q13442814 |
P356 | DOI | 10.1172/JCI118638 |
P8608 | Fatcat ID | release_jqupsdbe5ralhl2gvyq5smzb6i |
P932 | PMC publication ID | 507276 |
P698 | PubMed publication ID | 8621791 |
P2093 | author name string | C M Weyand | |
J J Goronzy | |||
D Schmidt | |||
P2860 | cites work | A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients | Q71668730 |
Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death | Q71669275 | ||
The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice | Q71678868 | ||
Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset | Q71693387 | ||
Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells | Q72087695 | ||
Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis | Q72347357 | ||
Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects | Q72574744 | ||
Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis | Q72646584 | ||
A subset of CD4+ thymocytes selected by MHC class I molecules | Q72671900 | ||
The role of the CD28 receptor during T cell responses to antigen | Q28263234 | ||
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis | Q34158788 | ||
Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis | Q34222528 | ||
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. | Q34300766 | ||
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells | Q34319909 | ||
Apoptosis and programmed cell death in immunity | Q36135180 | ||
Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients | Q36361765 | ||
The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory | Q36362035 | ||
Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". | Q36362764 | ||
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice | Q36362973 | ||
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. | Q36363643 | ||
Rheumatoid arthritis. Pathophysiology and implications for therapy | Q38019708 | ||
Predominantly T-Cell Infiltrate in Rheumatoid Synovial Membranes | Q39944481 | ||
Molecules involved in T-cell costimulation | Q40488866 | ||
HLA heterozygosity contributes to susceptibility to rheumatoid arthritis | Q40551519 | ||
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster | Q41471760 | ||
Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line | Q41695588 | ||
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 | ||
CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection | Q44197905 | ||
Interconversion of CD45R subsets of CD4 T cells in vivo | Q44877870 | ||
Genomic amplification with transcript sequencing | Q44961386 | ||
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells | Q45151385 | ||
Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity | Q46094710 | ||
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Q46925453 | ||
CD7- T cells represent a subset of normal human blood lymphocytes | Q52065356 | ||
CD28- T lymphocytes. Antigenic and functional properties. | Q52065463 | ||
CD7- T cells in rheumatoid arthritis | Q67536977 | ||
A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire | Q69110026 | ||
CD7-negative helper T cells accumulate in inflammatory skin lesions | Q71612713 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 2027-2037 | |
P577 | publication date | 1996-05-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity | |
P478 | volume | 97 |
Q34670370 | 4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease |
Q37790771 | A Practical Approach to the Flow Cytometric Detection and Diagnosis of T-Cell Lymphoproliferative Disorders |
Q48112621 | A fresh look at T cells in psoriasis. |
Q35909947 | A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells |
Q57226743 | Activating NK-cell receptors co-stimulate CD4+CD28−T cells in patients with rheumatoid arthritis |
Q47943623 | Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells. |
Q40398975 | Aging of the Immune System. Mechanisms and Therapeutic Targets |
Q24797866 | Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation |
Q38640148 | Aging, cytomegalovirus (CMV) and influenza vaccine responses |
Q37681485 | Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression |
Q53394501 | Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica. |
Q77627717 | Antigen-presenting cells in rheumatoid arthritis |
Q35553362 | Antigen-specific T cells in rheumatoid arthritis |
Q33915352 | Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation |
Q34221820 | Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells |
Q51871199 | Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. |
Q24807037 | Association of MHC and rheumatoid arthritis. HLA polymorphisms in phenotypic variants of rheumatoid arthritis |
Q48330739 | Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population |
Q89983758 | Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis |
Q30234766 | Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma |
Q34504806 | Atherosclerosis and connective tissue diseases |
Q33673310 | Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies |
Q50915395 | Autoimmune arthritis induces paired immunoglobulin-like receptor B expression on CD4+ T cells from SKG mice. |
Q27027444 | Autoimmune enteropathy with a CD8+ CD7- T-cell small bowel intraepithelial lymphocytosis: case report and literature review |
Q35800364 | Autophagy in autoimmune disease |
Q24813041 | Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis |
Q77734344 | Bone and cytokines: beyond IL-1, IL-6 and TNF-alpha |
Q37117934 | Breast abscess due to Salmonella Typhimurium in a patient with rheumatoid arthritis: a case report |
Q64054989 | CD28 CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection |
Q35679137 | CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells |
Q33529016 | CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis |
Q24808883 | CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression |
Q58796708 | CD28 pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death |
Q33572405 | CD28(-) T cells: their role in the age-associated decline of immune function |
Q41564272 | CD4+ CD7- T cells: a separate subpopulation of memory T cells? |
Q32044990 | CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems |
Q24670063 | CD4+CD28- costimulation-independent T cells in multiple sclerosis |
Q55511972 | CD4+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery. |
Q34546418 | CD8+CD28- T cells: certainties and uncertainties of a prevalent human T-cell subset |
Q33914271 | Cell proliferation and apoptosis in the immune system in the elderly |
Q42019369 | Challenges and promise for the development of human immune monitoring |
Q35605578 | Characterisation of the immune response to type I collagen in scleroderma |
Q56904794 | Characterization of CD28(-)CD4(+) T cells in living kidney transplant patients with long-term allograft acceptance |
Q35583440 | Chronic beryllium disease: immune‐mediated destruction with implications for organ‐specific autoimmunity |
Q35091286 | Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis |
Q24792089 | Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis |
Q44001527 | Clonal expansions in selected TCR BV families of rheumatoid arthritis patients are reduced by treatment with the TNFα inhibitors etanercept and infliximab |
Q40875588 | Clonal populations of T-cells in patients with B-cell malignancies |
Q39122674 | Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease |
Q38804454 | Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future? |
Q41481648 | Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow |
Q56908440 | Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells |
Q37206907 | Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis |
Q33846367 | Costimulatory mechanisms in the elderly |
Q56907492 | Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells |
Q42363220 | Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression. |
Q39283173 | Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges |
Q47443520 | DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system |
Q34474734 | DNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis |
Q45207731 | Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy |
Q37383981 | Defective expression of p56lck in an infant with severe combined immunodeficiency |
Q33646411 | Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis |
Q42363315 | Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis. |
Q53561906 | Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. |
Q33519353 | Detecting single-nucleotide polymorphism by single-nucleotide polymorphism interactions in rheumatoid arthritis using a two-step approach with machine learning and a Bayesian threshold least absolute shrinkage and selection operator (LASSO) model |
Q47759350 | Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis |
Q37454068 | Developments in the scientific understanding of rheumatoid arthritis |
Q28348358 | Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation |
Q40074042 | Distinct aging profiles of CD8+ T cells in blood versus gastrointestinal mucosal compartments |
Q44642515 | Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis |
Q40428698 | Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells |
Q33686997 | ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis |
Q64102310 | Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis |
Q60912812 | Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis |
Q37675607 | Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection |
Q40972080 | Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome |
Q47776925 | Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis |
Q81155956 | Flow cytometric analysis of human antigen-specific T-cell proliferation |
Q40778252 | Frequency and characteristics of circulating CD4(+) CD28(null) T cells in patients with psoriasis |
Q77162637 | Functional properties of CD4+ CD28- T cells in the aging immune system |
Q37829691 | Gain and loss of T cell subsets in old age--age-related reshaping of the T cell repertoire |
Q33805889 | HLA polymorphisms and T cells in rheumatoid arthritis |
Q77627706 | Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes |
Q33522918 | Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells |
Q26850549 | Human cytomegalovirus and autoimmune disease |
Q24791017 | Immune ablation and stem-cell therapy in autoimmune disease. Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation |
Q34777989 | Immune aging and autoimmunity |
Q34036703 | Immune aging and rheumatoid arthritis |
Q35198258 | Immunosenescence, autoimmunity, and rheumatoid arthritis |
Q37114482 | Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation |
Q33287471 | In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer |
Q47346714 | Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action |
Q35549148 | Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis |
Q33780032 | Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). |
Q36225887 | Inflammaging decreases adaptive and innate immune responses in mice and humans |
Q49693642 | Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis |
Q73165816 | Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis |
Q46025003 | Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis? |
Q77628789 | Involvement of CD4+,CD57+ T cells in the disease activity of rheumatoid arthritis |
Q38840304 | Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T Cells |
Q53278093 | Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia. |
Q42777634 | Leveraging blood and tissue CD4+ T cell heterogeneity at the single cell level to identify mechanisms of disease in rheumatoid arthritis. |
Q34152994 | Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments |
Q36368995 | Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis |
Q64240190 | Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma |
Q64229784 | Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis |
Q46819131 | Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells. |
Q36119464 | Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis |
Q37172115 | Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. |
Q36438043 | Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis |
Q35562281 | NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. |
Q42833030 | Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. |
Q38076350 | Novel mechanisms of action of the biologicals in rheumatic diseases. |
Q74140161 | Oligoclonal expansion of CD4(+)CD28(-) T lymphocytes in recipients of allogeneic hematopoietic cell grafts and identification of the same T cell clones within both CD4(+)CD28(+) and CD4(+)CD28(-) T cell subsets |
Q71838378 | Organ-specific disease provoked by systemic autoimmunity |
Q24296651 | PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? |
Q42648866 | Pathogenesis of rheumatoid arthritis |
Q33782717 | Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics |
Q36735976 | Perturbation of the T cell repertoire in rheumatoid arthritis |
Q42870348 | Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis |
Q28298650 | Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells |
Q35637105 | Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis. |
Q37089409 | Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. |
Q24797697 | Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis |
Q77347487 | Prognostic value of Th1/Th2 ratio in rheumatoid arthritis |
Q83017983 | Quantitative alterations of CD8+ T cells in juvenile idiopathic arthritis patients in remission |
Q35025444 | Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients |
Q37607081 | Rejuvenating the immune system in rheumatoid arthritis |
Q41591692 | Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? |
Q92913113 | Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis |
Q41697585 | Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation |
Q41985582 | Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulation. |
Q33555281 | Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging |
Q27693905 | Rheumatoid Arthritis: A Role for Immunosenescence? |
Q24792902 | Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells |
Q35720116 | Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence |
Q37892982 | Role of unusual CD4+ CD28- T cells in acute coronary syndrome |
Q53580597 | Rosmarinic acid induces apoptosis of activated T cells from rheumatoid arthritis patients via mitochondrial pathway. |
Q45569404 | Rosuvastatin induces apoptosis in CD4+CD28null T cells in patients with acute coronary syndromes |
Q37470923 | Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults |
Q36370648 | Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells |
Q44177491 | Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. |
Q74582450 | Simultaneous analysis of T cell clonality and cytokine production in rheumatoid arthritis using three-colour flow cytometry |
Q42159822 | Spatial map of human T cell compartmentalization and maintenance over decades of life |
Q35234747 | Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis |
Q37780978 | Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes |
Q47108142 | T Cell Homeostasis and Repertoire Contraction in Rheumatoid Arthritis. |
Q89688886 | T Lymphocyte Subsets Associated with Prevalent Diabetes in Veterans with and without HIV |
Q28396774 | T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases |
Q74404616 | T cell genetics and rheumatoid arthritis (RA) |
Q35200330 | T cell homeostasis in patients with rheumatoid arthritis |
Q33703402 | T cell immunosenescence in vitro and in vivo |
Q33536195 | T cell receptor repertoire in rheumatoid arthritis |
Q33676048 | T cell receptor usage in autoimmune disease |
Q36731766 | T cell subset-specific susceptibility to aging. |
Q26859971 | T-cell aging in rheumatoid arthritis |
Q35071556 | T-cell metabolism in autoimmune disease |
Q41452516 | T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices? |
Q38170328 | Targeting inflammation: impact on atherothrombosis |
Q35806766 | Telomere dysfunction, autoimmunity and aging. |
Q34051060 | Telomeres and immunological diseases of aging |
Q92571224 | The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament |
Q34562309 | The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I |
Q52017434 | The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15). |
Q41412396 | The T cell in the ageing individual |
Q43857531 | The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions |
Q24804863 | The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis |
Q61945657 | The expansion of CD4+CD28− t cells in patients with chronic kidney graft rejection |
Q40909251 | The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model |
Q58694765 | The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis |
Q103806791 | The immunology of rheumatoid arthritis |
Q38115131 | The influence of ageing on the development and management of rheumatoid arthritis |
Q36898613 | The janus head of T cell aging - autoimmunity and immunodeficiency |
Q38550407 | The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases |
Q36437991 | The repertoire of CD4+ CD28- T cells in rheumatoid arthritis |
Q35714970 | The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis |
Q28082856 | The story of CD4+ CD28- T cells revisited: solved or still ongoing? |
Q47346613 | The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation |
Q61946763 | Therapy with infliximab decreases the CD4+CD28? T cell compartment in peripheral blood in patients with rheumatoid arthritis |
Q73807442 | Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis |
Q33833231 | Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis |
Q37541433 | Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders |
Q33642739 | Vasculitic peripheral ulcerative keratitis |
Q83398658 | [A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation] |
Q81261692 | [T-lymphocytes--do they control rheumatic immune responses?] |
Search more.